Although it is universally accepted that FOXP3+ Tregs biological action aims at suppressing the immune response, the association between the FOXP3+ Tregs immunohistochemical expression and standard histological lesions seems to be controversial in primary as well as in secondary glomerulopathies. This evidence concerns the gene FOXP3 and lipoprotein glomerulopathy.